Tag: Filament Health (FH.NE)
-
![Today’s Idea: Filament Health’s (FH.NE) psychedelics play]()
Today’s Idea: Filament Health’s (FH.NE) psychedelics play
Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector was experiencing an unprecedented breakout period. Maybe it was because of mainstream media or perhaps it was my nagging parents, but I have always feared psychedelics. Back…
-
![Today’s Idea: Filament Health (FH.NE) Is All Natural]()
Today’s Idea: Filament Health (FH.NE) Is All Natural
Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic effects of lysergic acid diethylamide (LSD). Truly a mad chemist. Furthermore, Hofmann was also the first person to isolate, synthesize, and name the principal psychedelic compounds…
-
![Today’s Idea: Filament Health (FH.NE) Gaining Traction]()
Today’s Idea: Filament Health (FH.NE) Gaining Traction
Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple peer-reviewed studies, I adamantly believed psychedelics would melt your brain. In retrospect, that belief is just about as bogus as going to hell for premarital hand-holding.…
-
Filament Health (FH.NE) takes a natural approach to the $16 billion USD anxiety & depression market
Filament Health (FH.NE) is developing a pipeline of natural psychedelics products to treat mental health problems like depression and anxiety. August 3, 2021, FH received a patent for the technology used to transform psychedelic raw materials, like psilocybin-bearing mushroom, into pharma-grade extracts. “This approval represents important progress in the development of our IP,” stated Benjamin…
